Market Exclusive

Analyst Downgrades – HCP (NYSE:HCP) Stock Gets Downgraded By Goldman Sachs Group, Inc. (The) from Buy to Neutral

Analyst Ratings For HCP (NYSE:HCP)

Today, HCP (NYSE:HCP) stock was downgraded by Goldman Sachs Group, Inc. (The) from Buy to Neutral.

There are 1 sell rating, 14 hold ratings, 2 buy ratings on the stock.

The current consensus rating on HCP (NYSE:HCP) is Hold (Score: 2.06) with a consensus target price of $32.85 per share, a potential 3.98% upside.

Some recent analyst ratings include

Dividend information for HCP (NYSE:HCP)

HCP (NYSE:HCP) pays an annual dividend of Community Ranking: with a yield of 4.69% and an average dividend growth of -0.10% based on a 3 Year Average.

Dividend History for HCP (NYSE:HCP)

Recent Insider Trading Activity For HCP (NYSE:HCP)
HCP (NYSE:HCP) has insider ownership of 0.22% and institutional ownership of 88.44%.

Recent Trading Activity for HCP (NYSE:HCP)
Shares of HCP closed the previous trading session at 31.59 down -0.15 -0.47% with 3,303,960 shares trading hands.

Exit mobile version